New Delhi: Healthcare companies need financial discipline, but sustainable leadership in the sector depends equally on purpose, philosophy and the ability to take long-term strategic decisions, said Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare.
In a Spotlight Session moderated by Prathiba Raju, Senior Assistant Editor, ETHealthWorld, Shah reflected on Metropolis Healthcare’s journey from a promoter-led single laboratory to a business that has seen private equity investment and subsequently operated in public markets.
“The ones that really become successful in healthcare… are the ones who build purpose and philosophy as the core of it,” Shah said.
She noted that investors, whether private equity firms or public market participants, tend to evaluate businesses primarily through a financial lens. “The financial lens is important. But in healthcare, it is not the reality of life at all,” she said, adding that leadership teams must maintain a broader framework for measuring organisational performance.
Scale must translate into trust and integration
Discussing consolidation in diagnostics, Shah said size alone does not automatically create a stronger healthcare business. Diagnostics remains highly operational, fragmented and dependent on delivering consistent quality within short turnaround times across multiple locations.Metropolis, she said, operates across hundreds of cities and towns and manages thousands of test variants, making trust and execution critical to scaling successfully.
While scale can improve purchasing power and efficiencies in specialised testing, Shah cautioned that organised diagnostic providers often compete with an unregulated market where cost structures and quality standards differ sharply.
On acquisitions, she warned against using transactions merely to accumulate revenue or geographic presence.
“When you buy disorganised businesses just for scale, and you don’t have the ability to influence them… you are basically holding a portfolio of stocks, not an integrated chain,” Shah said.
For Metropolis, she said acquisitions must offer a strategic capability that can be integrated into the organisation and subsequently scaled. Difficult partnerships are a major warning sign. “When people are not understanding the larger picture, and everybody is interested in their own kingdom, to me that is difficult,” she said.
Long-term value over short-term pressure
Shah also stressed the importance of balancing immediate market expectations with future value creation. Asked whether she would accept unlimited private equity capital tied to a three-year exit horizon, she indicated that the decision would depend on whether that timeframe aligned with the company’s economics and strategic needs.She was clearer on long-term investment decisions: if an action weakened the stock price in the short term but strengthened the company five years later, she said she would still take it.
Her message for healthcare leaders was that scale, capital and market valuation matter—but only when they reinforce an organisation’s underlying purpose, quality and long-term strategic strength.
